Cormorant Asset Management

Cormorant Asset Management as of March 31, 2022

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 77 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Turning Point Therapeutics I 7.6 $99M 3.7M 26.85
Erasca (ERAS) 6.9 $90M 11M 8.60
Design Therapeutics (DSGN) 6.4 $83M 5.2M 16.15
Prometheus Biosciences 5.3 $69M 1.8M 37.76
Greenlight Biosciencs Hlds P Common Stock 4.8 $62M 6.7M 9.24
Apellis Pharmaceuticals (APLS) 4.4 $57M 1.1M 50.81
Revolution Medicines (RVMD) 3.9 $51M 2.0M 25.51
Edgewise Therapeutics (EWTX) 3.5 $45M 4.7M 9.70
Monte Rosa Therapeutics (GLUE) 3.2 $42M 3.0M 14.02
Forma Therapeutics Hldgs SHS 2.9 $38M 4.1M 9.30
Avidity Biosciences Ord (RNA) 2.9 $37M 2.0M 18.47
Tango Therapeutics (TNGX) 2.9 $37M 4.9M 7.58
Aerovate Therapeutics (AVTE) 2.6 $34M 1.8M 18.33
Helix Acquisition Corp Com Cl A 2.6 $33M 3.3M 10.14
Tarsus Pharmaceuticals (TARS) 1.8 $23M 1.4M 16.82
Stoke Therapeutics (STOK) 1.8 $23M 1.1M 21.05
Centessa Pharmaceuticals Sponsored Ads (CNTA) 1.7 $22M 2.5M 8.97
Chemocentryx 1.7 $22M 865k 25.07
Axonics Modulation Technolog (AXNX) 1.5 $20M 322k 62.60
Karuna Therapeutics Ord 1.5 $19M 150k 126.79
Miragen Therapeutics (VRDN) 1.4 $19M 1.0M 18.49
Verve Therapeutics (VERV) 1.2 $16M 701k 22.82
Bridgebio Pharma (BBIO) 1.2 $16M 1.6M 10.15
Adicet Bio (ACET) 1.1 $15M 750k 19.97
Immuneering Corp Class A Com (IMRX) 1.1 $15M 2.3M 6.47
Cytokinetics Com New (CYTK) 1.1 $15M 400k 36.81
Biomea Fusion (BMEA) 1.1 $14M 3.2M 4.46
Rocket Pharmaceuticals (RCKT) 1.1 $14M 869k 15.86
Pharvaris N V (PHVS) 1.0 $12M 685k 18.13
Longboard Pharmaceuticals In (LBPH) 0.9 $12M 2.3M 5.34
Alx Oncology Hldgs (ALXO) 0.9 $12M 712k 16.90
Rain Therapeutics 0.9 $12M 2.3M 5.07
Talaris Therapeutics 0.9 $12M 1.2M 9.84
Atea Pharmaceuticals (AVIR) 0.9 $11M 1.5M 7.22
Gh Research Ordinary Shares (GHRS) 0.9 $11M 608k 18.29
Igm Biosciences (IGMS) 0.8 $11M 402k 26.73
Ventyx Biosciences (VTYX) 0.8 $11M 785k 13.57
Horizon Therapeutics Pub L SHS 0.8 $11M 100k 105.21
Ambrx Biopharma Sponsored Ads 0.8 $10M 2.5M 4.12
Bioatla (BCAB) 0.8 $10M 2.0M 5.00
Vectivbio Hldg Ord Shs 0.8 $9.8M 2.1M 4.71
Biohaven Pharmaceutical Holding 0.7 $9.5M 80k 118.58
Intra Cellular Therapies (ITCI) 0.7 $9.2M 150k 61.19
Olema Pharmaceuticals (OLMA) 0.7 $8.9M 2.1M 4.26
Tyra Biosciences (TYRA) 0.6 $8.1M 757k 10.70
Praxis Precision Medicines I 0.6 $7.7M 752k 10.21
Ascendis Pharma A/s Sponsored Adr (ASND) 0.5 $5.9M 50k 117.36
Akero Therapeutics (AKRO) 0.4 $5.7M 404k 14.19
Keros Therapeutics (KROS) 0.4 $5.4M 100k 54.38
Beam Therapeutics (BEAM) 0.4 $5.2M 90k 57.30
Eledon Pharmaceuticals (ELDN) 0.4 $5.1M 1.3M 3.94
Elevation Oncology (ELEV) 0.4 $5.0M 2.0M 2.52
Vigil Neuroscience (VIGL) 0.3 $4.2M 617k 6.82
Mirati Therapeutics 0.3 $4.1M 50k 82.22
Pliant Therapeutics (PLRX) 0.3 $3.4M 482k 7.01
Iteos Therapeutics (ITOS) 0.2 $3.2M 100k 32.18
Icosavax 0.2 $3.0M 426k 7.04
Gelesis Holdings (GLSH) 0.2 $2.8M 626k 4.39
Pyxis Oncology Common Stock (PYXS) 0.2 $2.7M 669k 4.04
Harpoon Therapeutics 0.2 $2.7M 541k 4.97
Atreca Cl A Com (BCEL) 0.2 $2.5M 800k 3.17
Cabaletta Bio (CABA) 0.2 $2.3M 1.2M 2.03
Galecto (GLTO) 0.2 $2.2M 1.0M 2.20
Renovacor 0.2 $2.1M 500k 4.24
Meiragtx Holdings (MGTX) 0.2 $2.1M 150k 13.85
Astria Therapeutics (ATXS) 0.2 $2.0M 300k 6.71
Akouos 0.1 $1.9M 395k 4.75
Y Mabs Therapeutics (YMAB) 0.1 $1.8M 150k 11.88
Gossamer Bio (GOSS) 0.1 $1.7M 198k 8.68
Autolus Therapeutics Spon Ads (AUTL) 0.1 $1.6M 392k 4.17
Chemomab Therapeutics Sponsored Ads (CMMB) 0.1 $1.4M 288k 4.80
Anaptysbio Inc Common (ANAB) 0.1 $1.2M 50k 24.74
Precision Biosciences Ord 0.1 $1.1M 347k 3.08
Graphite Bio 0.1 $1.0M 203k 5.10
Imv 0.0 $337k 234k 1.44
Orchard Therapeutics Ads 0.0 $183k 257k 0.71
X4 Pharmaceuticals (XFOR) 0.0 $182k 104k 1.75